Scientific Associate Director
Takeda Pharmaceuticals
Burlington, Massachusetts
Saleem Shaik has been involved in the portfolio projects in industry and academic setting since 15 years with a focus on Clinical Biomarker, PK and Immunogenicity assessment, detecting and de-risking toxicities to improve the quality of biotherapeutic drugs.
He has published his work in top-tier journals and thise are all on novel cellular and molecular assays to investigate mechanism of toxicity to support clinical drug development, immunogenicity projects and screening for clinical translation of safety biomarkers.
He is currently in Takeda Pharmaceuticals, actively involved in drug development programs focussing on the Clinical Bioanalytical and immunogenicity risk eveluation and mitgation strtegies.
A Novel Method to Overcome ADA Interference in PK Assay
Monday, October 23, 2023
10:00 AM – 10:30 AM ET